6 d. ago Novo Nordisk India prioritises patient outcomes; revenue growth follows naturally, says Shrotriya

Novo Nordisk India prioritises patient outcomes; revenue growth follows naturally, says Shrotriya  The Economic Times

Politics

1 week ago Novo Nordisk Slashes Wegovy Price in India as Obesity Drug War Escalates

Novo Nordisk Slashes Wegovy Price in India as Obesity Drug War Escalates  Yahoo Finance

Events

1 week ago Novo Nordisk slashes Wegovy price in India as Lilly’s Mounjaro tops sales

Novo Nordisk slashes Wegovy price in India as Lilly’s Mounjaro tops sales  Seeking Alpha

Economics

2 w. ago Novo Nordisk cuts Wegovy price in India by up to 37% in rivalry with Eli Lilly's Mounjaro | Business News

Novo Nordisk cuts Wegovy price in India by up to 37% in rivalry with Eli Lilly's Mounjaro | Business News  Hindustan Times

Economics

2 w. ago Exclusive: Novo Nordisk cuts Wegovy price by up to 37% in India

Exclusive: Novo Nordisk cuts Wegovy price by up to 37% in India  Reuters

Politics

2 w. ago Exclusive: Novo Nordisk cuts Wegovy price by up to 33% in India, document shows

Exclusive: Novo Nordisk cuts Wegovy price by up to 33% in India, document shows  Reuters

Politics

2 w. ago Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India  NDTV

Events

2 w. ago Novo forges partnership with Emcure to expand Wegovy access in India

Novo forges partnership with Emcure to expand Wegovy access in India  Fierce Pharma

Politics

2 w. ago Novo Nordisk partners with Emcure to expand Wegovy's reach in India

Novo Nordisk partners with Emcure to expand Wegovy's reach in India  India Today

Politics

2 w. ago Emcure Pharma Partners With Novo Nordisk To Launch Weight Loss Injection In India

As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra in India.

Politics

2 w. ago Watch: Pharma Executive Collapses Next To Trump During White House Event On Obesity Drug Price Cuts

The man was later identified as Gordon Findlay, an executive of the pharma company Novo Nordisk.

Events